[New trends and novel possibilities in the radiodiagnosis of lung cancer].
In recent years there have been significant changes in the management of lung cancer. In 2009 a new staging system became effective while in 2011 a new adenocarcinoma classification was introduced. Molecular biology, genetics with hybrid multimodal imaging progressed greatly. New biopsy needles were developed for the histological analysis in molecular pathology. Role of LDCT screening in early diagnosis of lung cancer became evident and working groups put it into practice. Integrated and multiparametric devices facilitate more accurate patient follow-up with new biomarkers and newly developed contrast materials. The future of radiology is in the combined use of anatomical, functional and molecular medical imaging.